|
Volumn 26, Issue 6, 2000, Pages 62-72
|
Antipsychotics, risk of QT prolongated and torsades de pointes;Antipsychotiques et sécurité cardio-vasculaire: Données actuelles sur les allongements de l'intervalle QT et le risque d'arythmies ventriculaires
a b c |
Author keywords
Antipsychotic; Drug interactions; Prolongation of QT interval; Torsades de pointes
|
Indexed keywords
AMIODARONE;
AMISULPRIDE;
APRINDINE;
BENZAMIDE DERIVATIVE;
BEPRIDIL;
BUMETANIDE;
BUTYROPHENONE DERIVATIVE;
CARDIOQUINE;
CHLORPROMAZINE;
CICLETANINE;
CLOZAPINE;
DIHYDROQUINIDINE;
DISOPYRAMIDE;
DROPERIDOL;
FLECAINIDE;
FUROSEMIDE;
HALOPERIDOL;
ISORYTHM;
NEUROLEPTIC AGENT;
OLANZAPINE;
PHENOTHIAZINE DERIVATIVE;
PIMOZIDE;
PIRETANIDE;
QUETIAPINE;
QUINIDINE;
QUINIDINE 5 ETHYL 5 PHENYLBARBITURATE;
QUINIDINE ACID SULFATE;
QUINIDINE ARABOGALACTAN SULFATE;
RISPERIDONE;
SERTINDOLE;
SOTALOL;
SULTOPRIDE;
THIORIDAZINE;
UNINDEXED DRUG;
ZIPRASIDONE;
ARRHYTHMOGENESIS;
ARTICLE;
DISEASE PREDISPOSITION;
DRUG CONTRAINDICATION;
DRUG SAFETY;
HUMAN;
LONG QT SYNDROME;
PSYCHOSIS;
QT INTERVAL;
RISK ASSESSMENT;
RISK FACTOR;
ANTIPSYCHOTIC AGENTS;
ELECTROCARDIOGRAPHY;
HUMANS;
LONG QT SYNDROME;
RISK FACTORS;
SCHIZOPHRENIA;
TORSADES DE POINTES;
|
EID: 0034491215
PISSN: 00137006
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (59)
|
References (44)
|